Your browser doesn't support javascript.
loading
Assessment of dengue virus inactivation in random donor platelets using amotosalen and ultraviolet A illumination.
Kumar, Ankit; Tiwari, Aseem Kumar; Kumar, Satendra; Biswas, Ashutosh; Singh, Gurpreet; Chatterjee, Kabita; Chakroborty, Sourit; Sunil, Sujatha.
Afiliación
  • Kumar A; Vector Borne Diseases Group, International Centre For Genetic Engineering And Biotechnology, Aruna Asaf Ali Marg, New Delhi, India.
  • Tiwari AK; Department of Transfusion Medicine, Medanta- The Medicity, Gurgaon, Haryana, India.
  • Kumar S; Hemogenomics Pvt Ltd, Bangalore, Karnataka, India.
  • Biswas A; Department of Medicine, AIIMS, New Delhi, India.
  • Singh G; Hemogenomics Pvt Ltd, Bangalore, Karnataka, India.
  • Chatterjee K; Department of Transfusion Medicine, AIIMS, New Delhi, India.
  • Chakroborty S; Hemogenomics Pvt Ltd, Bangalore, Karnataka, India.
  • Sunil S; Vector Borne Diseases Group, International Centre For Genetic Engineering And Biotechnology, Aruna Asaf Ali Marg, New Delhi, India.
Asian J Transfus Sci ; 16(1): 67-72, 2022.
Article en En | MEDLINE | ID: mdl-36199414
ABSTRACT

OBJECTIVES:

The study objective was evaluation of amotosalen and ultraviolet A (UVA) illumination-based inactivation of dengue virus (DENV) in blood platelets. MATERIALS AND

METHODS:

Whole blood was collected from healthy donors and platelet concentrates were prepared at a tertiary care hospital in Gurugram, India. Platelet units collected from five blood group matched individuals were pooled and spiked with DENV. The spiked platelet units were subjected to amotosalen treatment followed by UVA illumination, to evaluate the efficiency of this method for viral inactivation. The treated platelet units were evaluated for the presence of infectious DENV. Amotosalen levels were quantified in the treated samples using high-performance liquid chromatography.

RESULTS:

The presence of replicating DENV was not observed in spiked platelet units treated with amotosalen and UVA illumination, whereas untreated units contained actively replicating DENV. Amotosalen levels were found to be in the permissible range after photochemical inactivation.

CONCLUSIONS:

Amotosalen/UVA pathogen inactivation treatment showed efficient inactivation of DENV in platelet components. Therefore, it seems to be a promising method for mitigating the risk of dengue transmission through transfusion of potentially contaminated platelet components in dengue-endemic countries such as India.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 3_ND Problema de salud: 2_enfermedades_transmissibles / 3_dengue / 3_neglected_diseases Tipo de estudio: Clinical_trials Idioma: En Revista: Asian J Transfus Sci Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 3_ND Problema de salud: 2_enfermedades_transmissibles / 3_dengue / 3_neglected_diseases Tipo de estudio: Clinical_trials Idioma: En Revista: Asian J Transfus Sci Año: 2022 Tipo del documento: Article País de afiliación: India
...